| dbo:abstract
|
- جوان إي. بيرغر- سويني، عالمة أعصاب أمريكية والرئيس الثاني والعشرين لكلية الثالوث، في هارتفورد في كونيتيكت. (ar)
- Joanne E. Berger-Sweeney (born September 21, 1958) is an American neuroscientist and the 22nd president of Trinity College, Hartford, Connecticut. She is the first African-American and the first woman to serve in the position. Earlier in her career, Berger-Sweeney did proof-of-concept work on galantamine (brand name Razadyne), the second-most used drug to treat Alzheimer's disease. (en)
|
| dbo:academicDiscipline
| |
| dbo:award
| |
| dbo:birthDate
| |
| dbo:birthName
| |
| dbo:birthPlace
| |
| dbo:doctoralAdvisor
| |
| dbo:doctoralStudent
| |
| dbo:institution
| |
| dbo:knownFor
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 19873 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:after
| |
| dbp:alt
|
- Joanne Berger-Sweeney in 2012 (en)
|
| dbp:awards
|
- Alumni Achievement Award, Johns Hopkins University (en)
- Posse Star, Posse Foundation (en)
|
| dbp:before
| |
| dbp:birthDate
| |
| dbp:birthName
| |
| dbp:birthPlace
|
- Los Angeles, California (en)
|
| dbp:caption
|
- Joanne Berger-Sweeney in 2012 (en)
|
| dbp:children
| |
| dbp:doctoralAdvisor
| |
| dbp:doctoralStudents
| |
| dbp:education
| |
| dbp:fields
| |
| dbp:knownFor
|
- Proof-of-concept work on galantamine, a drug used to treat Alzheimer's disease (en)
|
| dbp:name
|
- Joanne Berger-Sweeney (en)
|
| dbp:nationality
| |
| dbp:signature
|
- Joanne_Berger-Sweeney_Signature.png (en)
|
| dbp:spouse
| |
| dbp:title
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:workplaces
| |
| dbp:years
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- جوان إي. بيرغر- سويني، عالمة أعصاب أمريكية والرئيس الثاني والعشرين لكلية الثالوث، في هارتفورد في كونيتيكت. (ar)
- Joanne E. Berger-Sweeney (born September 21, 1958) is an American neuroscientist and the 22nd president of Trinity College, Hartford, Connecticut. She is the first African-American and the first woman to serve in the position. Earlier in her career, Berger-Sweeney did proof-of-concept work on galantamine (brand name Razadyne), the second-most used drug to treat Alzheimer's disease. (en)
|
| rdfs:label
|
- جوان بيرغر-سويني (ar)
- Joanne Berger-Sweeney (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Joanne Berger-Sweeney (en)
|
| is dbo:president
of | |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is dbp:president
of | |
| is foaf:primaryTopic
of | |
.jpg?width=300)
.jpg){kind=link}
